Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
Funder: National Institutes of Health
AGENCY
National Institutes of Health
PROGRAM
Discretionary
AMOUNT
—
CLOSES
Oct 28, 2027
Description
The purpose of this notice of funding opportunity (NOFO) is to identify modifiable mechanisms and therapeutic targets to address central nervous system (CNS) complications associated with human immunodeficiency virus (HIV). The initiative supports a phased research approach beginning with the identification of patient phenotypes characterized by convergent pathophysiological features, followed by the discovery and experimental validation of molecular mechanisms using innovative in-vitro and in-vivo models. The goal of this NOFO is to advance therapeutic target, and intervention discovery to address the multifactorial and heterogeneous nature of HIV-associated CNS dysfunction.
Eligibility
Public and State controlled institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); State governments; Special district governments; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; Independent school districts; Private institutions of higher education; Native American tribal governments (Federally recognized); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments
Contact
Additional details
- Department
- HHS-Nih11
- Funding instrument
- Grant
- Cost sharing required
- No
- Archived
- Dec 27, 2027
Opportunity number: RFA-MH-27-125
Quote this number when you contact the agency or apply.